CERUS CORP (CERS) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US1570851014
CERUS CORP financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 233.80 m USD |
| Operating income | -8.68 m USD |
| EBIT | -6.94 m USD |
| Net income | -15.63 m USD |
| Diluted EPS – continuing operations | -0.08 USD |
Full history since 1997, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CERUS CORP
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells intended for transfusion; INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced; and INTERCEPT Illuminator, an LED-based device for blood component treatment. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was formerly known as CERUS TECHNOLOGIES INC and changed its name to Cerus Corporation in July 1996. The company was incorporated in 1991 and is headquartered in Concord, California.
More stocks
- Bemobi Mobile Tech S.A (BMOB3.SA)
- Hey-Song Corp (1234.TW)
- Suzhou Weizhixiang Food Co. Ltd. (605089.SS)
- Ningbo Xianfeng New Material (300163.SZ)
- Zhejiang Weigang Technology Co. Ltd. A (001256.SZ)
- C4 Therapeutics, Inc. (CCCC)
- Funko, Inc. (FNKO)
- Better Collective A/S (BETCO DKK.CO)
- Doright Co.Ltd. (300950.SZ)
- PARKE BANCORP, INC. (PKBK)
- Jilin Jinguan Electric Co Ltd Class A (300510.SZ)
- Moso Power Supply Technology Co Ltd (002660.SZ)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.